Skip to content

Evaluation of the efficacy of fresh bamboo juice in a population with borderline elevated lipids - a prospective, randomized, parallel, blank-controlled trial pilot study

Evaluation of the efficacy of fresh bamboo juice in a population with borderline elevated lipids - a prospective, randomized, parallel, blank-controlled trial pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000045
Enrollment
Unknown
Registered
2023-09-15
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marginal elevation of blood lipids

Interventions

control:dietary instruction
intervention:dietary instruction + fresh bamboo juice

Sponsors

Affiliated Hospital of Jiangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) BMI=24 kg/m2; (2) In line with Western medicine borderline hyperlipidemia diagnosis; (3) Age =18 years old, male or female; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with serious heart, brain and hematopoietic system and other primary diseases, combined with serious liver and kidney damage, there are malignant tumors; (2) in preparation for pregnancy, pregnancy or lactation period; (3) Combined with a major mental illness, unable to cooperate or unwilling to cooperate; (4) known allergy to the drug ingredient; (5) People who have taken weight-loss or lipid-regulating drugs in the past 3 months, affecting the judgment of the results; (6) Weak spleen and stomach, easy loose stool diarrhea, or accompanied by intestinal diseases; (7) Participants in other clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
tetrapolipidemia;

Secondary

MeasureTime frame
Serum metabolomics;IL-6;TNF-a;Physical improvement;MCP-1;weight;NF-?B;

Countries

China

Contacts

Public ContactChen Xiaofan;Yi xingqian

The Affiliated Hospital of Jiangxi University of Chinese Medicine

xiaofanci122306@163.com18507915566;18770010316

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026